Navigation Links
JDRF Illinois Names Allscripts CEO Glen Tullman 'Best of Illinois' for His Efforts to Find a Cure for Type 1 Diabetes

CHICAGO, May 26 /PRNewswire/ -- The Juvenile Diabetes Research Foundation Illinois, the state chapter of the leading charitable funder and advocate of type 1 diabetes research worldwide, has named Glen Tullman, Chief Executive Officer of Allscripts (Nasdaq: MDRX), its "Best of Illinois" for his service on the Illinois Board of Directors, on the International Board, and for his support of the organization's efforts in developing an artificial pancreas.


JDRF Illinois honored Mr. Tullman at its annual Best of Illinois dinner May 21. The event raised more than $1 million, including over $500,000 for the Artificial Pancreas Program. The development of an artificial pancreas, one of JDRF's top research priorities, would enable a person with diabetes to maintain normal glucose levels by continuously monitoring blood glucose levels and then providing an exact dose of insulin automatically through an integrated pump.

"I am honored to be recognized by JDRF Illinois, however the real reward will come only when we win the race to find a cure for diabetes once and for all," said Mr. Tullman, whose son and niece have type-1 diabetes. "I'm very optimistic that, through JDRF's cutting-edge research, which includes the Artificial Pancreas and other important breakthroughs, and the generosity of tens of thousands of supporters around the world, we will find a cure for this terrible disease, which millions of us confront in our own families every day."

Mr. Tullman is a longtime active supporter and advocate for JDRF and has contributed to raising millions of dollars in search of a cure, along with his family's own contributions, which are measured in the millions. He also has encouraged Allscripts, the leading provider of Electronic Health Records, to become a lead sponsor of JDRF volunteer fundraising events in Illinois, North Carolina, Vermont and other states where the company has offices.

"Glen Tullman is a passionate and selfless advocate of the JDRF cause who has worked to advance the cause for many years both through his volunteer activities and his many generous gifts to the Foundation," said Patrick Reedy, Executive Director of JDRF Illinois. "Glen not only is a visionary leader in his own business of transforming our healthcare system using technology, but one of the many extraordinary Illinois leaders who share a common interest in supporting cutting edge research and technology that will lead to a cure for type 1 diabetes."


The Juvenile Diabetes Research Foundation International was founded in 1970 by the parents of children with type 1 diabetes and is the world's largest charitable funder and advocate of type 1 diabetes research. The mission of JDRF is to find a cure for diabetes and its complications through the support of research. JDRF provided more than $137 million to diabetes research in FY 2007, and is responsible for more than $1.16 billion in direct funding since it was founded. JDRF annually receives top rankings from independent sources that rate charitable giving. For more information please visit

Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Passage of Illinois House Bill 2290 Adds Crucial Due Process Protection Governing Sterilization of Adults With Disabilities
2. Illinois Medical District Presented with "Good Neighbor Award"
3. ASG Business Development Team Expands in Illinois
4. Illinois Soybean Association to Participate in Global Child Nutrition Forum in South Africa
5. New Illinois Prosecution Unit Helps Protect Women Against Violence
6. 5th Anniversary Illinois Lions Clubs Walk for Sight
7. Illinois-Based AthletiCo Opens Milestone 50th Physical Therapy Center
8. 57 (More) Reasons to Buy a Contract From College Illinois!(SM)
9. Illinois Hospitals Hit Hard By Recession
10. The Healy Law Firm Represents Plaintiff in $12 Million Settlement with Clark USA Over Fatal Illinois Oil Refinery Accident
11. Illinois Lottery Releases New MS Ticket, Dash! For Cash
Post Your Comments:
(Date:11/27/2015)... ... November 27, 2015 , ... Lizzie’s Lice Pickers just announced a special promotion ... off of their purchase of lice treatment product. In addition, customers will receive a ... company spokesperson. “Finding lice is a sure way to ruin the holidays, so we ...
(Date:11/27/2015)... Viejo, CA (PRWEB) , ... November 27, 2015 , ... ... for use in Final Cut Pro X. With ProSidebar: Fasion, video editors can ... or use ProSidebar as a minimalist title opener. Utilize presets featuring self-animating drop ...
(Date:11/27/2015)... ... 2015 , ... Consistent with the Radiology Business Management ... Radiology Marketing Programs meeting will showcase some of the best 2015 radiology ... Palace in Las Vegas with a pre-conference session on a collaborative approach for ...
(Date:11/27/2015)... ... November 27, 2015 , ... A simply groundbreaking television series, ... interesting show that delves into an array of issues that are presently affecting Americans. ... from open dialogue, this show is changing the subjects consumers focus on, one episode ...
(Date:11/27/2015)... (PRWEB) , ... November 27, 2015 , ... ... Health-E-minds, an innovative online platform for mental health and wellness consultation, has collaborated ... This partnership will bridge the knowledge gap experienced by parents and bring advice ...
Breaking Medicine News(10 mins):
(Date:11/26/2015)... Nov. 26, 2015 Research and Markets ... the "2016 Future Horizons and Growth Strategies ... Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Emerging ... --> --> This ... the Italian therapeutic drug monitoring market, including emerging ...
(Date:11/25/2015)...  Amgen (NASDAQ: AMGN ) today announced the ... the United States (U.S.) Food and ... to Humira ® (adalimumab). Amgen believes this submission ... FDA and represents Amgen,s first BLA submission using the ... M.D., executive vice president of Research and Development at ...
(Date:11/25/2015)... Nov. 25, 2015  ARKRAY USA ... to provide evidence demonstrating the accuracy of its blood ... on Insulin Resistance, Diabetes and Cardiovascular Disease in ... the Company,s GLUCOCARD ® 01 meter and the ... requirements. The ability to accurately measure glucose levels in ...
Breaking Medicine Technology: